Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?

Crit Care. 2018 Nov 1;22(1):289. doi: 10.1186/s13054-018-2231-6.

Authors

Patrick M Honore¹, David De Bels², Leonel Barreto Gutierrez², Sebastien Redant², Rachid Attou², Andrea Gallerani², Herbert D Spapen³

Affiliations

¹ ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein, 4, 1020, Brussels, Belgium. [email protected].
² ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein, 4, 1020, Brussels, Belgium.
³ Universitair Ziekenhuis Brussel, VUB University, Brussels, Belgium.

No abstract available

Publication types

Letter
Comment

MeSH terms

Candida
Critical Illness
Echinocandins
Humans
Micafungin*
Obesity, Morbid*

Substances

Echinocandins
Micafungin